Your browser doesn't support javascript.
loading
Whole-exome sequencing reveals genetic variants in ERC1 and KCNG4 associated with complete hydatidiform mole in Chinese Han women.
Yu, Yan; Lu, Bingjian; Lu, Weiguo; Li, Shuang; Li, Xiuqin; Wang, Xinyu; Wan, Xiaoyun; Chen, Yaxia; Feng, Suwen; Jia, Yao; Yang, Ru; Tang, Fangxu; Li, Xiong; Zhang, Shulan; Wang, Xinyan; Wei, Heng; Peng, Zhilan; Lu, Lin; Zhong, Huizhen; Zhao, Linjun; Huang, Zhangqian; Lin, Lin; Shen, Weihong; Lu, Yan; Cao, Zhu; Zou, Jian; Ma, Yuejiang; Chen, Xiaojing; Tian, Qifang; Lu, Shiming; Liu, Pengyuan; Ma, Ding; Xie, Xing; Cheng, Xiaodong.
Afiliação
  • Yu Y; Key Laboratory of Women's Reproductive Health of Zhejiang Province, Women's Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Lu B; Department of Surgical Pathology, Women's Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Lu W; Department of Gynecologic Oncology, Women's Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Li S; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Li X; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
  • Wang X; Department of Gynecologic Oncology, Women's Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Wan X; Department of Gynecologic Oncology, Women's Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Chen Y; Department of Gynecologic Oncology, Women's Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Feng S; Department of Gynecologic Oncology, Women's Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Jia Y; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Yang R; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Tang F; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Li X; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Zhang S; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
  • Wang X; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
  • Wei H; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
  • Peng Z; Department of Obstetrics and Gynecology, West China Second Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Lu L; Department of Obstetrics and Gynecology, West China Second Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Zhong H; Department of Obstetrics and Gynecology, Ningbo Women and Children's Hospital, Ningbo, Zhejiang, China.
  • Zhao L; Department of Obstetrics and Gynecology, Ningbo Women and Children's Hospital, Ningbo, Zhejiang, China.
  • Huang Z; Department of Obstetrics and Gynecology, Shaoxing Women and Children Hospital, Shaoxing, Zhejiang, China.
  • Lin L; Zhejiang University Hospital, Zhejiang University, Hangzhou, Zhejiang, China.
  • Shen W; Zhejiang University Hospital, Zhejiang University, Hangzhou, Zhejiang, China.
  • Lu Y; Department of Gynecologic Oncology, Women's Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Cao Z; Institute for Translational Medicine School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Zou J; Key Laboratory of Women's Reproductive Health of Zhejiang Province, Women's Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Ma Y; Key Laboratory of Women's Reproductive Health of Zhejiang Province, Women's Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Chen X; Key Laboratory of Women's Reproductive Health of Zhejiang Province, Women's Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Tian Q; Key Laboratory of Women's Reproductive Health of Zhejiang Province, Women's Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Lu S; Department of Gynecologic Oncology, Women's Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Liu P; Department of Clinical Laboratory, Women's Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Ma D; Institute for Translational Medicine School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Xie X; Sir Run Run Shaw Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Cheng X; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Oncotarget ; 8(43): 75264-75271, 2017 Sep 26.
Article em En | MEDLINE | ID: mdl-29088863
ABSTRACT
Complete hydatidiform mole (CHM) is a rare pregnancy-related disease with invasive potential. The genetics underlying the sporadic form of CHM have not been addressed previously, but maternal genetic variants may be involved in biparental CHM. We performed whole-exome sequencing of 51 patients with CHM and 47 healthy women to identify genetic variants associated with CHM. In addition, candidate variants were analyzed using single base extension and Matrix Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry in 199 CHM patients and 400 healthy controls. We validated candidate variants using Sanger sequencing in 250 cases and 652 controls, including 205 new controls. Two single nucleotide polymorphisms, c.G48C(p.Q16H) inERC1 and c.G1114A(p.G372S) in KCNG4, were associated with an increased risk of CHM (p<0.05). These variants may contribute to the pathogenesis of CHM and could be used to screen pregnant women for this genetic abnormality.
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China